glp-1 for dementia GLPs Reduce Risk #Shorts GLP-1 Medications Associated with Reduced
Description
Ozempic is FDA-approved for diabetes not weight loss
However, one study into the use of one of these medications, Mounjaro, found that approximately 500,000 people in the UK have used the drug privately for weight loss since 2023
That makes I&I drug candidates potential targets for licensing deals
The aim is to make sure food is not the only option
By combining structured monitoring with patient education, clinicians can deliver safe and effective care beyond the clinic walls
These diabetes and weight loss medications are not for everyone
